An emerging class of orexin-based drugs are on the cusp of disrupting care for sleep disorders — and potentially much more.
Orexin is a neurotransmitter, a chemical in the brain that attaches to the orexin receptor 1 (OX1R) or orexin receptor 2 (OX2R). These receptors regulate sleep and wakefulness, stress responses ...